✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Jubilant Pharmova Ltd.

JUBLPHARMA

Market Cap
₹17,820 Cr.
P/E
21.23

Jubilant Pharmova Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
17,820 Cr
PE
PE
21.23
Prom Holding
Prom Holding
50.68 %
ROE (%)
ROE (%)
1.42
ROCE (%)
ROCE (%)
6.23
Div Yield (%)
Div Yield (%)
0.89
Sales
Sales
7,234 Cr
OPM (%)
OPM (%)
16.22 %
Debt to Equity
Debt to Equity
0.63
View more
Edit Ratio's
About
Jubilant Pharmova Limited, formerly known as Jubilant Life Sciences Limited, operates globally… Read more
Low
702
52W Range
High
1310
  • Jubilant Pharmova
  • Alembic Pharma
  • Natco Pharma
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
62 %
(as of Mar 18)
Historic
Acetic Anhydride - Domestic Market Share
0.06 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.06 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.01 %
(as of Feb 21)
Historic
Neurological - Market Share
0.02 %
(as of Jul 22)
Historic
Pharmaceutical Sector - Market Share
0.03 %
(as of Jul 22)
Historic
Vitamin & Dietary Supplements - Market Share
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up - Contract Research

Location Wise Break-Up - Pharmaceuticals

Location Wise Break-Up

Operating Profit Break-Up

Capex

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Australia DMF fillings (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • US DMF Filings (.)
      Source
    • Canada DMF fillings (.)
      Source
    • Japan DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Aegis Logistics Ltd.
    • Time Technoplast Ltd.
    • GMM Pfaudler Ltd.
    • Balaji Amines Ltd.
    • Deep Energy Resources Ltd. - (Amalgamated)
    FAQs on Jubilant Pharmova Ltd. Business

    Jubilant Pharmova Limited operates globally in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Novel Drugs with a strong manufacturing presence in Radiopharmaceutical products for regulated markets.

    Jubilant Pharmova major competitors are Alembic Pharma, Natco Pharma, Caplin Point Lab, Sanofi India, Marksans Pharma, Eris Lifesciences, Astrazeneca Pharma I.
    Market Cap of Jubilant Pharmova is ₹17,820 Crs.
    While the median market cap of its peers are ₹15,838 Crs.

    Jubilant Pharmova seems to be less financially stable compared to its competitors.
    Altman Z score of Jubilant Pharmova is 3.39 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Jun Sep Jun Sep Sep Dec
    Investor Presentation May Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec Mar Jun Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Jubilant Pharmova Ltd.
    View the discussion on ValuePickr
    Jubilant vs Syngene in CDMO - UnseenValue
    Chemical Sector
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Chemical Industry - Top Down - Capital Mind
    Battery Chemistry Of EV's - Value Educator
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Understanding the Agri-Inputs Industry - PPFAS
    Pesticides Industry Primer - ValuePickr
    Flavours & Fragrances: Everything you need to know about this sector! - Anish Moonka
    Overview of Shelf-Life Extension and Aroma Chemicals - Camlin Fine Sciences
    Understanding The Dyes & Pigments Industry - Tycoon Mindset
    A Primer On Speciality Chemicals - The Investing Hub
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material